September 2015: Val M. Runge, MD, a note from the Editor

2015 is the 50th anniversary for Investigative Radiology. For the last 22 years of this era, I have had the honor and pleasure of being the Editor-in-Chief. As throughout its history, the journal continues to focus on cutting edge research, with an emphasis on technological innovation that impacts clinical diagnostic imaging. In this anniversary issue, each major area in imaging is reviewed by leading clinicians and scientists from across the world, discussing state of the art and future directions. The articles therein are written to provide valuable insight and guidance to clinicians and researchers involved in medical imaging for years to come.

Current Issue Highlights


Val M. Runge, MD

ISSN: 0020-9996

Online ISSN: 1536-0210

Frequency: 12 issues / year

Ranking: Radiology, Nuclear Medicine, and Medical Imaging 10/125

Impact Factor: 4.437

Special Issue on Contrast Media
Investigative Radiology will publish a special issue on 'Contrast Media' in 2016. The focus is on current significant advances in knowledge regarding contrast media. Relevant topics include basic science investigations, clinical trials, innovative clinical applications, and safety. With regard to clinical papers, all organ and disease areas will be considered. Submitted manuscripts should significantly advance our knowledge concerning contrast media in MR, CT, or ultrasound.

Manuscripts will be accepted for consideration beginning in October. The deadline for submission is January 31, 2016. All papers will be subject to peer review by experts in the field and must comply with the Journal's Instructions for Authors.

We look forward to receiving your submissions.

Best regards,

Val M. Runge, MD,
Editor-in-Chief, Investigative Radiology

Guest Editors:
Peter Caravan, PhD
Marco Essig, MD
Richard Katzberg, MD
Alexander L. Klibanov, PhD
Michael V. Knopp, MD, PhD
Hubertus Pietsch, PhD
Michael F. Tweedle, PhD
Study Highlights 'Important Safety Issue'
A press release for Investigative Radiology shows new results in animals highlighting a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast agents used in millions of patients each year.